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a b s t r a c t
More than 450 post-translational modiﬁcations (PTMs) are known, however, currently only
some of those can be enriched and analyzed from complex samples such as cell lysates.
Therefore, we need additional methods and concepts to improve our understanding about
the dynamic crosstalk of PTMs and the highly context-dependent regulation of protein func-
tion by so-called ‘PTM codes’. The mere focus on afﬁnity-based enrichment techniques may
not be sufﬁcient to achieve this ambitious goal. However, the complementary use of two-
dimensional chromatography-based strategies such as COFRADIC and ChaFRADIC mightTM crosstalk opennewavenues for enriching a variety of so far inaccessible PTMs for large-scale proteome
studies.
© 2014 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
Association (EuPA). This is an open access article under the CC BY-NC-SA license. The relevance of post-translational
odiﬁcations
rganisms have to adapt continuously their physiological pro-
esses in order to maintain homeostasis under a large range
f environmental changes. Compared to gene expression and
rotein translation, post-translational modiﬁcations (PTMs)
nd protein degradation enable a faster regulation of cel-
ular processes. Thus, PTMs allow the precise and dynamic
esponse to internal and external stimuli, modulating for
nstance the subcellular localization, activity, stability and
nteraction of proteins. Consequently, understanding this
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sensitive and complex system is essential for cell biology, dis-
ease prevention and development of therapeutic approaches
[1,2].
Currently, over 450 PTMs [3,4] are listed in the UniProt
database including the most prominent members such as
phosphorylation, glycosylation, ubiquitination and acety-
lation. The number of experimentally observed PTMs literally
exploded in the past 10 years [5,6] mainly owing to the recent
improvements in mass spectrometry (MS) and the availabilityraphy; ChaFRADIC, charge-based fractional diagonal chromatog-
oxide afﬁnity chromatography; LC, liquid chromatography; MS,
cation exchange chromatography; TAILS, terminal amine isotopic
ften – ISAS – e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany.
of more sensitive and faster mass analyzers.
However, often more than 50% of MS/MS spectra acquired
in an LC–MS/MS run cannot be identiﬁedbydatabase searches.
Suchunmatched spectra canarise from e.g. (a) contaminations
European Proteomics Association (EuPA). This is an open access
enses/by-nc-sa/3.0/).
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Fig. 1 – Strategies for MS-based analysis of PTMs. (i) In
top-down experiments intact and puriﬁed proteins are
analyzed. As prior digestion is not required, the
comprehensive identiﬁcation and mapping of PTMs is
possible. (ii) Middle-down approaches produce relatively
long peptide-stretches that can potentially contain multiple
PTMs. Like in bottom-up experiments the modiﬁed
peptides can be enriched to obtain speciﬁc sub-proteomes
(e.g. phosphoproteome, acetylome, N-terminome). (iii) In
bottom-up strategies shorter peptides are generated. This
is usually accompanied by a loss of information about166 e u pa open proteo
such as polymers or other biomolecules, (b) co-isolation of
peptides (and such contaminations) so that MS/MS spectra
represent fragment ions derived from a mixture of precursor
ions, (c) point mutations or (d) sequences that are incor-
rectly annotated in databases, (e) degradation products, (f)
enzymatic mis-cleavages and in-source decay [7,8], and (g)
unknown or unanticipated PTMs (and their combinations,
respectively). The possible extent of protein modiﬁcation is
well represented by histones, which are also among the best-
characterized proteins. All core histones can bemodiﬁed by up
to eight different PTMs (acetylation, phosphorylation, mono-,
di- and tri-methylation, butyrylation, crotonylation and propi-
onylation) at the same time, while the individual sites can be
modiﬁed by different PTMs with occupancies varying between
<1% and 100% [9,10]. In histones these PTMs can act in con-
cert so that the highly context-dependent and combinatorial
pattern of different modiﬁcations referred to as ‘PTM code’,
modulates anddeﬁnes theﬁnal cellular output [11]. A similarly
high degree of modiﬁcation was shown for the tumor suppres-
sor p53, with 10 different PTMs that act in concert and thus
can induce different cellular responses. For both examples,
different PTM codes could be mapped to speciﬁc molecular
functions [11], however, this required a large number of elab-
orate experiments and studies.
Nowadays, large-scale characterization of PTMs is per-
formed routinely [12–17] and improved methods enable PTM
localization and quantiﬁcation with high conﬁdence [18–22].
Nevertheless, this vibrant research ﬁeld is still emerging and
accompanied by incomplete assignment of identiﬁed PTM
sites to speciﬁc cellular functions [23]. Although extensive
databases about PTMs exist, complete ‘PTMcatalogs’ [23] sum-
marizing all possiblemodiﬁcations (or sites) for protein entries
are still far from reality. Such catalogs will represent valuable
resources for both functional/structural studies andmodeling.
This holds true for extensively analyzed PTMs such as
phosphorylation or glycosylation, but even more for the huge
proportion of so far known but largely uncharacterized PTMs
[6]. Because many PTMs have a low stoichiometry and thus
are almost inaccessible for the global proteome analysis of
complex samples such as cell lysates, their detection requires
speciﬁc enrichmentprior to analysis. For somePTMsantibody-
or afﬁnity-based enrichment is routinely used, but most PTMs
remain hidden from large-scale MS-based detection owing
to the lack of dedicated enrichment methods. Hence, there
is a strong need for alternative and versatile strategies for
PTM enrichment that provide high sensitivity and ﬂexibility,
to allow for a more comprehensive analysis of PTMs and PTM
codes in the future.
2. Strategies for MS-based analysis of PTMs
In general there are three strategies to analyze proteins via MS:
(i) top-down, (ii) middle-down and (iii) bottom-up (see Fig. 1).
In top-down proteomics intact proteins are analyzed,
potentially revealing complete protein PTM patterns such that
the information about the number, type and the localiza-
tion of PTMs is retained [24]. One substantial advantage is
the capability to determine the relative abundance of differ-
ent proteoforms and therefore their relative proportion in thecomplex PTM patterns of different proteoforms.
sample. Relative site occupancies can be calculated for dif-
ferent PTMs to determine stoichiometries [24]. Furthermore,
top-down allows characterizing structural changes induced
upon PTM of proteins [25]. However, certain limitations still
impede the dissemination of top-down as routinely used
method for high-throughput PTM analysis [26]. So far efﬁcient
fragmentation is mainly achieved for small proteins (<30kDa)
and the need for elaborate pre-fractionation involves high
amounts of starting material [26–28], while PTM enrichment
is much more challenging on the protein compared to the
peptide level.
In contrast, bottom-up strategies mostly generate shorter
peptides [8,29] (6–30 amino acids [8,29]), which, compared to
proteins, are less heterogeneous and thus can be separated
and detected more efﬁciently. This allows detection down to
the amol range, even for complex samples. The physicochemi-
cal properties of peptides can be exploited effectively to enrich
for certain PTMs that can be mapped with high localization
probabilities [30,31]. However, the improved enrichment and
detection capabilities of bottom-up approaches are accom-
panied by an inherent loss of qualitative and quantitative
information, considerably impeding the differentiation of pro-
teoforms, PTM stoichiometry and consequently also PTM
crosstalk [32]. Despite those inherent limitations, peptide-
centric bottom-up proteomics is still the method-of-choice
to screen for PTMs and their dynamics, providing important
information about PTM localization and changes between dif-
ferent cellular states or time points.More recently, a promising alternative, so-called middle-
down, was established. Here, proteases that generate peptides
in the range of 3–9kDa are used, allowing the identiﬁcation of
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Fig. 2 – Separation principle of two-dimensional re-chromatography strategies. All strategies follow the same three steps to
enrich the PTM of interest: (1) initial separation of a complex sample, (2a+b) changing the chromatographic behavior of a
certain subclass of peptides and (3) re-chromatography – in (A) and (B) under the same conditions – to enrich for speciﬁc
PTM-peptides. During positive selection (A) the PTM-peptide of interest is speciﬁcally derivatized to induce a retention time
shift in the following second dimension. Vice versa, in negative selection (B) all other peptides are derivatized in order to
induce a retention time shift. (C) Changing the conditions between ﬁrst and second dimension chromatography, as depicted
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tere for the pH can also lead to an altered elution proﬁle as
arger peptide-stretches that potentially reveal more complex
TM patterns. This approach basically combines the strengths
f top-down and bottom-up, however without completely
liminating their weaknesses. Thus, PTM peptide enrichment
echniques can be applied and the context of contiguous PTMs
ay be recovered, potentially providing more information
bout global PTM stoichiometry [6,26].
. The need for enrichment
egardless of which approach is pursued, the low abundance
f PTMs renders a dedicated enrichment essential to lower
ample complexity, to enhance the dynamic range for detec-
ion and thereby the speciﬁcity of analysis [24,33]. Especially
or top-down strategies, enrichment is rather restricted to
educing sample complexity by fractionation and puriﬁca-
ion of the proteins of interest, respectively [24,28,34–37]. Inonstrated by Hennrich et al. [47].
contrast, bottom-up experiments allow a more straightfor-
ward separation of the small proportion of PTM-peptides from
the immense excess of unmodiﬁed peptides. The applied
strategies mostly utilize certain structural or chemical char-
acteristics of the respective PTM to achieve a dedicated
enrichment. The general bottleneck here is the ultimate goal
to address as many PTMs as possible, and not only the
most abundant ones. For the latter, efﬁcient methods are
established, but even these are often restricted to subclasses
of the speciﬁc PTM-proteome, due to inherent preferences
and limitations either of the method, or the preceding sam-
ple preparation steps. Even widely-established methods such
as metal oxide afﬁnity chromatography (MOAC), used for
enriching phospho- and glycopeptides, show preferences for
speciﬁc subclasses, that may be altered based on the applied
protocol. For other PTMs such as ubiquitination, lysine acet-
ylation, acylation and methylation, speciﬁc enrichment is
achieved using immunoafﬁnity-based strategies, whereas e.g.
mics
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the enrichment of SUMOylated species was achieved using a
genetically introduced afﬁnity tag [38]. Unfortunately, those
approaches are often expensive and time-consuming, as e.g.
immunoafﬁnity enrichment requires either purchase or gen-
eration of speciﬁc antibodies. These, however, often show low
speciﬁcity and demand huge amounts of starting material
(often 10mg and more), which does not comply with the anal-
ysis of clinical samples or primary tissues. For instance, most
large-scale ubiquitin studies used proteasome inhibitors to
increase the endogenous levels of ubiquitination and thus the
number of identiﬁed sites [39].
In order to improve our presently limited knowledge
about PTMs in cells, important steps will be (i) to fur-
ther improve already established strategies, as has been
successfully demonstrated e.g. for TiO2 [18,40–43] and (ii)
to develop novel strategies for enrichment and separation
of so far inaccessible or rather uncharacterized PTMs. We
think that exploiting techniques that involve a dedicated
chemical derivatization of peptides in combination with spe-
ciﬁc enrichment/depletion of certain peptide classes holds a
strong potential to ﬁll the current gap of knowledge. Two-
dimensional re-chromatography strategies such as ‘combined
fractional diagonal chromatography’ (COFRADIC) [44,45], and
our recently introduced derivative ‘charge-based fractional
diagonal chromatography’ (ChaFRADIC) [46] are highly ﬂex-
ible and offer a variety of alternative applications for the
enrichment of PTMs. The general concept is to (i) separate
and fractionate a complex peptide sample under robust chro-
matographic conditions, (ii) to employ a dedicated chemical
or enzymatic derivatization step to alter the chromatographic
behavior of a certain peptide class, and (iii) to separate the
derivatized fractions again under the same conditions. As
illustrated in Fig. 2, peptides of interest retain their previous
retention time window, whereas others shift considerably out
of that window – or vice versa.
4. Fractional diagonal chromatography
approaches
The original COFRADIC concept was published in 2002 by
Gevaert et al. [44]. Here, in the primary LC run a complete cell
lysatewas separated via reversed phase chromatography, frac-
tions were collected every minute and methionine-containing
peptides were oxidized using H2O2. Afterwards, all fractions
were re-injected and separated under the same conditions.
Thus, due to the oxidation, methionine-containing peptides
shifted to earlier retention times, whereas unmodiﬁed pep-
tides retained their retention times. The same group later
demonstrated further applications of COFRADIC for enrich-
ment of N-terminal peptides, cysteine-containing peptides
[48,49], phosphopeptides [50], glycopeptides [51] and nitro-
sylated peptides [52]. The ChaFRADIC approach utilizes an
optimized strong cation exchange chromatography (SCX)-
based separation of peptides, based on their charge states
at pH 2.7, which is mainly deﬁned by the N-terminal amine
group and Lys, Arg and His side chains. We demonstrated the
proof-of-principle by enriching N-terminal peptides from Sac-
charomyces cerevisiae using only 50g protein per condition.
After only 10h of LC–MS/MS measuring time we could identify4 ( 2 0 1 4 ) 165–170
1459 non-redundant N-terminal peptides whereby only 40% of
the obtained fractions were measured. Before, Henrich et al.
used a pH shift between two SCX runs to selectively alter the
elution proﬁle of phosphopeptides [47] (Fig. 2).
Many PTMs bear charged or ionizable groups (e.g. GPI
anchors, arginylation, phosphorylation, sulfation, ubiquit-
ination, SUMOylation, certain types of glycosylation) that
may be used to add/remove charges by means of chemi-
cal/enzymatic derivatization or by shifting the pH, in order
to induce a change in their chromatographic behavior. SCX-
based strategies such as ChaFRADIC or the approach by Hen-
rich et al. therefore offer a new set of possibilities for dedicated
enrichment of so far inaccesible PTMs, and, based on the dif-
ferent separation principle, are complementary to COFRADIC.
In ChaFRADIC less fractions have to be collected (usually only
fractions containing net charges +1, +2, +3, +4 and higher),
converging high sensitivity, robustness and throughput. Once
the reproducible and robust charge-based HPLC separation
is established, the same system can be further adapted to
target other PTM classes, supposing a speciﬁc derivatiza-
tion step leading to a deﬁned change of net charge can be
applied.
5. COFRADIC and ChaFRADIC as versatile
tools for future PTM-research
The general concept renders COFRADIC and ChaFRADIC mul-
tifunctional, highly ﬂexible and well adjustable for the speciﬁc
context of the user. Moreover, as mentioned earlier, both
methods can be used for positive or negative selection of
peptide classes. Although establishing and maintaining this
technology is more challenging than other methods such as
MOACand furthermoremay require the use of dedicatedHPLC
system, the general strategy of using two-dimensional re-
chromatography setups offers unrivaled possibilities to enrich
for different classes of PTMs. It can be adapted to other
chromatography modes, further expanding the set of possi-
ble applications. Notably, for some applications transferring
the system from HPLCs to cartridges or tips may sufﬁce,
thus considerably facilitating the procedure and reducing the
accompanied costs.
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